Chronic kidney disease: the aging organ nobody monitors

Your kidneys filter 50 gallons (190 liters) of blood every day, removing waste, balancing electrolytes, regulating blood pressure, and producing hormones that control red blood cell production. They are among the hardest-working organs in your body — and among the least monitored.

After age 40, kidney filtration rate declines by 0.5–1.0 mL/min per year. By 70, you may have lost 25–30% of your peak kidney function. For most people, this gradual decline causes no symptoms and goes entirely undetected. But for the estimated 850 million people worldwide living with some form of chronic kidney disease — many of them undiagnosed — this silent decline is already accelerating their biological aging and dramatically increasing their cardiovascular risk.

The 2024 KDIGO guidelines emphasize a critical point: early detection and intervention can slow or halt kidney disease progression. Yet fewer than 10% of people with early-stage CKD know they have it. The markers that reveal kidney stress — creatinine and urea/BUN — are available in any basic blood panel, but most people have never been taught how to interpret them.

What you’ll learn:

• How kidney aging works and what accelerates it
• How to read and interpret your kidney function markers (eGFR, creatinine, BUN)
• The connection between kidney health, cardiovascular disease, and biological age
• Evidence-based strategies to protect and preserve kidney function

---

Quick answer

Chronic kidney disease is kidney structure or function abnormality lasting at least three months, usually classified by cause, eGFR, and albuminuria. The practical point for aging is simple: CKD can be silent for years, and cardiovascular risk often rises before anyone feels kidney symptoms.

The two highest-yield checks are blood-based eGFR and urine albumin-to-creatinine ratio (UACR). Creatinine-based eGFR is useful but can be misleading in very muscular or low-muscle people, so cystatin C can help confirm kidney function when results do not fit the person.

Key facts

• eGFR estimates filtration, while UACR detects kidney damage and vascular risk that eGFR alone can miss.
• KDIGO 2024 classifies CKD by cause, GFR category, and albuminuria category.
• Diabetes, hypertension, cardiovascular disease, family history, older age, and repeated kidney stressors increase CKD risk.
• CKD is a cardiovascular-risk condition; many people with CKD die from cardiovascular disease before kidney failure.
• Kidney protection usually starts with blood pressure control, glucose control, sodium reduction, NSAID caution, appropriate medications, and individualized protein guidance.

---

How kidneys age

Kidney aging is both a structural and functional process that begins earlier than most people realize.

Quick definition: Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function, present for ≥3 months, with implications for health. It is staged by eGFR (estimated glomerular filtration rate) and albuminuria.

The structural changes

• Nephron loss: Each kidney contains approximately 1 million nephrons (filtration units) at birth. Starting around age 30–40, you begin losing nephrons — approximately 6,000–10,000 per year. By age 70, you may have lost 30–40% of your nephrons. Unlike liver cells, nephrons do not regenerate.

• Cortical thinning: The kidney cortex (outer layer where filtration occurs) thins with age, and the kidneys physically shrink — losing approximately 10% of volume per decade after age 50.

• Vascular sclerosis: Blood vessels within the kidney harden and narrow, reducing blood flow to remaining nephrons and impairing their filtration capacity.

Why it accelerates

Several factors dramatically worsen kidney aging:

• Hypertension: High blood pressure is both a cause and consequence of kidney disease. Uncontrolled hypertension damages the delicate glomerular capillaries — the tiny blood vessels where filtration occurs.

• Diabetes: Type 2 diabetes is the #1 cause of kidney failure worldwide. Glycation damages the glomerular basement membrane, progressive[ly] increasing permeability and reducing filtration efficiency.

• NSAIDs: Regular use of ibuprofen, naproxen, and other non-steroidal anti-inflammatory drugs reduces renal blood flow and can cause cumulative damage. This is one of the most underrecognized causes of accelerated kidney aging.

• Dehydration: Chronic inadequate hydration forces the kidneys to concentrate urine more aggressively, increasing stress on tubular cells and promoting kidney stone formation. For people with diabetes, extreme-heat safety also requires a personal plan for cooling, fluids, glucose checks, and medicine storage.

---

Understanding your kidney markers

eGFR: the headline number

eGFR (estimated glomerular filtration rate) is the single most important kidney function marker. It estimates how many milliliters of blood your kidneys filter per minute, calculated from serum creatinine (plus age, sex, and race in some formulas).

eGFR (mL/min/1.73m²)	Stage	Kidney function
≥90	G1 (Normal)	Normal or high function
60–89	G2 (Mildly decreased)	Mild reduction — common after 60
45–59	G3a (Mild-moderate)	Moderate reduction — intervention needed
30–44	G3b (Moderate-severe)	Significant impairment
15–29	G4 (Severe)	Preparation for renal replacement
<15	G5 (Kidney failure)	Dialysis or transplant needed

Key context: A 70-year-old with eGFR of 65 may have age-appropriate kidney function, while the same eGFR in a 40-year-old signals a problem. The trajectory matters more than any single number — declining eGFR over serial measurements is more concerning than a single low reading.

Creatinine: what it means and its limitations

Creatinine is a waste product of muscle metabolism, filtered exclusively by the kidneys. When kidney function declines, creatinine accumulates in the blood.

The sarcopenia trap: Because creatinine comes from muscle, people with low muscle mass (sarcopenia, common in elderly) can have deceptively “normal” creatinine despite impaired kidney function. A creatinine of 0.8 mg/dL in a 75-year-old woman with significant muscle loss may actually represent poor kidney function — but the eGFR formula will overestimate her function. That is one common reason a person can see high cystatin C with normal creatinine.

The 2024 KDIGO guidelines recommend using cystatin C (a protein-based marker less affected by muscle mass) alongside creatinine for more accurate eGFR estimation in elderly or sarcopenic patients.

Urea/BUN

Urea (BUN) is another waste product filtered by the kidneys, but it is less specific than creatinine — levels can rise with high protein intake, dehydration, GI bleeding, and certain medications. BUN/creatinine ratio can help differentiate pre-renal (dehydration, heart failure) from intrinsic kidney disease. For a detailed comparison of what each marker measures and when one is more useful than the other, see BUN vs creatinine: which kidney marker matters more for longevity.

Albuminuria: the early warning

Albumin in the urine (albuminuria) is often the earliest sign of kidney damage — appearing before eGFR declines. A urine albumin-to-creatinine ratio (UACR) test can detect microalbuminuria, signaling glomerular damage.

UACR (mg/g)	Classification
<30	Normal
30–300	Moderately increased (microalbuminuria)
>300	Severely increased (macroalbuminuria)

Recommendation: Request both serum creatinine (for eGFR) and a spot urine albumin-to-creatinine ratio (UACR) annually after age 40, or earlier if you have diabetes, hypertension, or a family history of kidney disease.

---

The kidney-heart-aging connection

CKD is not just a kidney problem — it is a systemic accelerator of aging, primarily through its intimate connection with cardiovascular disease.

Cardiorenal syndrome

The kidneys and heart are so interconnected that damage to one invariably affects the other. CKD patients have 5–10x higher cardiovascular mortality than the general population. In fact, most people with moderate CKD die of cardiovascular disease long before they ever need dialysis.

The mechanisms include:

• Blood pressure dysregulation — kidneys control blood pressure through the renin-angiotensin system
• Volume overload — impaired sodium excretion increases blood volume and cardiac workload
• Arterial stiffness — uremic toxins accelerate vascular calcification
• Anemia — reduced erythropoietin production (a kidney hormone) impairs oxygen delivery

Accelerated biological aging

CKD is one of the strongest accelerators of biological aging. Patients with CKD show:

• Accelerated epigenetic aging on biological clocks
• Elevated inflammatory markers (hs-CRP, IL-6)
• Premature telomere shortening
• Accelerated immunosenescence
• Sharply reduced Klotho — the kidneys are the primary source of this anti-aging protein, and declining kidney function means declining Klotho, which further accelerates vascular aging and inflammation
• Higher rates of sarcopenia, cognitive decline, and frailty

This bidirectional relationship means that preserving kidney function is one of the most impactful longevity interventions, and slowing biological aging helps preserve kidney function.

---

6 evidence-based kidney protection strategies

1. Control blood pressure aggressively

Target: <130/80 mmHg (per 2024 KDIGO guidelines)

Hypertension is the most modifiable risk factor for kidney disease progression. Every 10 mmHg increase in systolic blood pressure accelerates eGFR decline. In people with CKD, blood pressure control is the single most important intervention.

Approach: Lifestyle first (sodium reduction to <2,300 mg/day, regular exercise, weight management, stress reduction). If medication is needed, ACE inhibitors and ARBs are preferred — they provide specific renal protection beyond blood pressure lowering.

2. Manage blood sugar

Target: HbA1c <7% for diabetics; <5.7% for prevention

Diabetic nephropathy is the #1 cause of kidney failure. Strict glucose control in early diabetes can prevent or delay kidney damage. SGLT2 inhibitors — a newer class of diabetes medications — have shown remarkable kidney-protective effects even in non-diabetic CKD patients, earning them specific recommendation in the 2024 KDIGO guidelines.

3. Stay properly hydrated

Target: 1.5–2.5 liters (50–85 oz) of water daily (adjust for climate and activity)

Adequate hydration reduces the concentration workload on your kidneys, helps flush waste products, and reduces kidney stone risk. However, excessive water intake provides no additional benefit and can be harmful in advanced CKD.

Practical marker: Aim for pale yellow urine. If it is dark yellow consistently, you are likely underhydrated.

4. Reduce sodium intake

Target: <2,300 mg/day (ideally <1,500 mg for those with hypertension or CKD)

High sodium intake directly increases blood pressure and causes kidney hyperfiltration — the kidneys working overtime, which accelerates nephron loss. The majority of dietary sodium comes from processed foods, restaurant meals, and packaged snacks — not the salt shaker.

5. Be cautious with NSAIDs

Impact: Regular NSAID use reduces renal blood flow and can cause cumulative kidney damage

Occasional ibuprofen or naproxen use is generally safe for healthy kidneys. But regular use (several times per week for weeks or months) — particularly in people over 60 or those with existing kidney impairment — can cause significant, sometimes irreversible damage.

Alternative approaches: Acetaminophen (paracetamol) for mild pain (processed by the liver, not kidneys). Topical NSAIDs for localized pain. Physical therapy and exercise for chronic musculoskeletal pain.

6. Optimize protein intake (do not over- or under-consume)

Target: 0.8–1.0 g/kg/day for early CKD; 1.0–1.2 g/kg/day for healthy kidneys

The relationship between protein and kidney health is nuanced. Excessive protein increases the kidneys’ filtration workload (hyperfiltration) and can accelerate progression in existing CKD. However, inadequate protein promotes sarcopenia — which paradoxically worsens kidney function markers (lower creatinine masking true decline) and overall mortality.

For healthy kidneys: adequate protein (1.0–1.2 g/kg) with good hydration is not harmful. For established CKD (stage 3+): discuss protein targets with a nephrologist.

---

Kidney health and biological age

Kidney function markers — particularly creatinine and urea/BUN — are core inputs to biological age calculators like PhenoAge and KDM. This is not arbitrary: creatinine and BUN reflect the combined burden of muscle mass, metabolic health, hydration, and renal function — making them composite aging markers.

A person with strong kidney function typically has:

• Lower biological age
• Better cardiovascular health
• Lower systemic inflammation
• Preserved muscle mass

Protecting kidney function is simultaneously one of the best ways to protect your biological age.

---

How SuperAge helps you monitor kidney-relevant metrics

SuperAge lets you enter kidney biomarker values from your blood work (creatinine, BUN, UACR) and combines them with the lifestyle factors that determine kidney health trajectory over time.

Blood pressure and cardiovascular health

SuperAge monitors your heart rate variability, resting heart rate, and cardiovascular fitness — metrics intimately connected to the cardiorenal axis that determines kidney aging.

Hydration and activity

The app tracks your daily activity and movement patterns. Consistent exercise and adequate hydration are two of the most impactful kidney-protective behaviors.

Your biological age, tracked

Because kidney markers are core inputs to biological age calculations, SuperAge’s biological age score indirectly reflects your kidney health trajectory. When your overall health metrics improve through better activity, sleep, and stress management, your kidneys benefit too.

---

Frequently asked questions

How do I know if my kidneys are healthy?

Request a basic metabolic panel (includes serum creatinine, from which eGFR is calculated) and a spot urine albumin-to-creatinine ratio (UACR). Together, these two tests can detect 90% of kidney problems. The tests are inexpensive, widely available, and should be part of annual bloodwork after 40.

Is kidney function decline inevitable with aging?

Gradual eGFR decline of 0.5–1.0 mL/min per year after 40 is common but not universal. Some people maintain stable kidney function well into their 80s. The difference appears to be driven by blood pressure control, metabolic health, hydration, and avoidance of nephrotoxins (NSAIDs, contrast dye, certain medications). For a detailed look at what a normal year-over-year kidney trajectory looks like — and the threshold that separates biological aging from accelerated decline — see our eGFR slope guide.

Can you improve kidney function once it has declined?

In early stages (G1–G2), addressing risk factors (blood pressure, blood sugar, hydration, NSAID cessation) can stabilize and sometimes slightly improve eGFR. In moderate-advanced stages (G3+), the goal shifts to slowing progression. True regeneration of lost nephrons is not currently possible — prevention is always more effective than treatment.

Does high protein intake damage kidneys?

In healthy kidneys: no evidence that protein intake up to 1.2 g/kg/day causes harm. In existing CKD (stage 3+): excessive protein can accelerate progression, and protein should be moderated to 0.6–0.8 g/kg/day under medical supervision. The key distinction is whether kidneys are healthy or already impaired.

Why do doctors not routinely screen for kidney disease?

This is changing. The 2024 KDIGO guidelines strongly recommend screening with both eGFR and UACR for at-risk populations (diabetes, hypertension, cardiovascular disease, family history, age >60). Many standard panels include creatinine but not UACR — request both specifically if you have any risk factors.

---

Key takeaways

• Kidney function declines 0.5–1% per year after 40 — silently, with no symptoms until advanced stages. 850 million people worldwide have CKD, many undiagnosed
• CKD is a cardiovascular disease accelerator: Most CKD patients die of heart disease, not kidney failure. The kidney-heart connection makes kidney protection a longevity priority
• Two simple tests detect 90% of kidney problems: eGFR (from creatinine) and UACR (from urine). Request both annually after 40
• Blood pressure is the #1 modifiable factor: Target <130/80 mmHg. Every 10 mmHg increase accelerates kidney decline
• Prevention beats treatment: Lost nephrons do not regenerate. Protect what you have through blood pressure control, hydration, blood sugar management, and NSAID avoidance

---

Start protecting your kidneys today

Your kidneys have been filtering your blood without complaint for decades. The least you can do is check in on them — a simple blood and urine test is all it takes to know where you stand.

Ready to take a whole-body approach? Download SuperAge and start tracking the cardiovascular and metabolic metrics that reflect your kidney health alongside your biological age.

---

References

1. Kidney Disease: Improving Global Outcomes (KDIGO). (2024). “Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.” https://kdigo.org/guidelines/ckd-evaluation-and-management/
2. KDIGO. (2024). “KDIGO 2024 CKD Guideline PDF.” https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf
3. Centers for Disease Control and Prevention. (2024). “Chronic Kidney Disease Basics.” https://www.cdc.gov/kidney-disease/about/index.html
4. Centers for Disease Control and Prevention. (2025). “Screening for Chronic Kidney Disease.” https://www.cdc.gov/kidney-disease/hcp/ckd-screening/index.html
5. GBD Chronic Kidney Disease Collaboration. (2020). “Global, regional, and national burden of chronic kidney disease, 1990-2017.” The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30045-3/fulltext
6. Denic A et al. (2016). “The substantial loss of nephrons in healthy human kidneys with aging.” Journal of the American Society of Nephrology. https://pubmed.ncbi.nlm.nih.gov/27797974/
7. Levey AS and Inker LA. (2020). “GFR as the gold standard: estimated, measured, and true.” American Journal of Kidney Diseases. https://pmc.ncbi.nlm.nih.gov/articles/PMC7808232/
8. Heerspink HJL et al. (2020). “Dapagliflozin in patients with chronic kidney disease.” New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/32970396/

---

Last updated: 2026-06-07. This article is regularly reviewed to ensure accuracy.